Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

NCT02860234 · clinicaltrials.gov ↗

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
RADIATION: intensity modulated radiotherapy
PROCEDURE: DRE-Endoscopy-MRI-CEA
PROCEDURE: Nonoperative Management
PROCEDURE: Local Excision
PROCEDURE: Total Mesorectal Excision
BEHAVIORAL: Quality of Life Questionnaires

Sponsor

Peking University Cancer Hospital & Institute